| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Monte Rosa Therapeutics, Inc.'s insiders have reduced their positions by a net 13 shares worth roughly $137. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), GLUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.69M | - | - | |
| CEO | 585.0K | $13.56M | - | |
| Other | 67.8K | $1.58M | - | |
| COO | 62.4K | $248.2K | - | |
| Other | 60.6K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Champoux Jennifer | Chief Operating Officer | Sale+OE10b5-1 | 2,176 | $19.00 | $41,344.00 | -3.4% | -29.4% | - | |
| Jun 17, 2026 | Townson Sharon | Chief Scientific Officer | Sale+OE10b5-1 | 3,000 | $19.00 | $57,000.00 | -4.2% | -29.4% | - | |
| Jun 1, 2026 | Warmuth Markus | President &CEO | Sell10b5-1 | 5,466 | $19.44 | $106,253.04 | -0.9% | -29.1% | - | |
| May 29, 2026 | Townson Sharon | Chief Scientific Officer | Sale+OE10b5-1 | 6,000 | $19.87 | $119,220.00 | -8.1% | -27.3% | - | |
| May 27, 2026 | Champoux Jennifer | Chief Operating Officer | Sale+OE10b5-1 | 2,175 | $20.00 | $43,500.00 | -3.4% | -24.0% | - | |
| May 22, 2026 | Champoux Jennifer | Chief Operating Officer | Sale+OE10b5-1 | 2,176 | $19.00 | $41,344.00 | -3.4% | -21.4% | - | |
| May 21, 2026 | Manning Anthony M. | Director | Sale+OE | 10,000 | $18.01 | $180,100.00 | - | -16.5% | - | |
| May 1, 2026 | Warmuth Markus | President &CEO | Sell10b5-1 | 5,467 | $18.92 | $103,446.57 | -0.9% | +20.6% | - | |
| Apr 14, 2026 | Warmuth Markus | President &CEO | Sell | 8,000 | $17.64 | $141,124.80 | -1.3% | +25.6% | - | |
| Apr 9, 2026 | Nickson Philip | Chief Business &Legal Officer | Sell | 5,845 | $17.69 | $103,412.66 | -9.6% | +33.3% | - |